Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences,...
Immunotherapy Efficacy Shown Through New Delivery Approach
Intrathecal (IT), intravenous (IV), and Nivolumab (anti-PD-1) immunotherapy were found to be safe and prolong...
EMA Releases Mid-Point Regulatory Science Strategy Study
The European Medicines Agency (EMA) has released a paper summarizing its Regulatory Science Strategy (RSS)...
Nasal Spray Effective Against Recent Variants – Research
Researchers have identified a molecule that is particularly successful in preventing sickness caused by all...
First Gene Therapy Comes Into Picture For AADC Deficiency
In the final draft guidance rolled out by the National Institute for Health and Care...
Australia Offers Hope For Drug Resistant Epilepsy Patients
More than 150,000 Australians and 50 million people across the world are affected by epilepsy,...
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that the company will...
Critical Medicine Shortages – A Growing Concern For The EMA
During its meeting in March 2023, the Management Board of the European Medicines Agency (EMA)...
Tardigrade Proteins Can Do Wonders To Certain Pharma Drugs
The study of how the microscopic creatures called tardigrades can survive extreme scenarios has led...
Medicine Price Negotiations – Pathways Chalked By The CMS
The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how...
